Patent Analysis of Four Lamiaceae-Derived Plants: A Medicinally Active Resource against New Health Challenges †
Abstract
:1. Introduction
2. Background
2.1. Salvia Genus
2.2. Ocimum Genus
2.3. Lavandula Genus
2.4. Origanum Genus
3. Resource and Methodology
4. Results and Discussions
4.1. Patent Analysis of Different Medicinally Active Plants
4.2. Relevant Patents of Using Different Medicinally Active Plants against SARS-CoV-2
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Petrovska, B.B. Historical review of medicinal plants’ usage. Pharmacogn. Rev. 2012, 6, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Nieto, G. Biological activities of three essential oils of the Lamiaceae family. Medicines 2017, 4, 63. [Google Scholar] [CrossRef] [PubMed]
- Brandão, L.B.; Santos, L.L.; Martins, R.L.; Rodrigues, A.B.L.; da Costa, A.L.P.; Faustino, C.G.; de Almeida, S. The potential effects of species Ocimum basilicum L. on health: A review of the chemical and biological studies. Pharmacogn. Rev. 2022, 16, 22–26. [Google Scholar] [CrossRef]
- Kumar, V.; Andola, H.C.; Lohani, H.; Chauhan, N. Pharmacological review on Ocimum sanctum Linnaeus: A queen of herbs. J. Pharm. Res. 2011, 4, 366–368. [Google Scholar]
- Rubab, S.; Hussain, I.; Khan, B.A.; Unar, A.A.; Abbas, K.A.; Khichi, Z.H.; Khan, M.; Khanum, S.; Rehman, K.U.; Khan, H. Biomedical Description of Ocimum basilicum L. J. Islam. Int. Med. Coll. (JIIMC) 2017, 12, 59–67. [Google Scholar]
- Chiang, L.C.; Ng, L.T.; Cheng, P.W.; Chiang, W.; Lin, C.C. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin. Exp. Pharmacol. Physiol. 2005, 32, 811–816. [Google Scholar] [CrossRef]
- Ahmet, A.; Ismihan, G.; Hamdi, M.G.; Bektas, T.; Julia, S. In Vitro antimicrobial and antiviral activities of the essential oil and various extracts of Salvia cedronella Boiss. J. Med. Plants Res. 2009, 3, 413–419. [Google Scholar]
- Petitjean, S.J.; Lecocq, M.; Lelong, C.; Denis, R.; Defrère, S.; Mariage, P.-A.; Alsteens, D.; Pilette, C. Salvia miltiorrhiza Bunge as a Potential Natural Compound against COVID-19. Cells 2022, 11, 1311. [Google Scholar] [CrossRef]
- Tshilanda, D.D.; Ngoyi, E.M.; Kabengele, C.N.; Matondo, A.; Bongo, G.N.; Inkoto, C.L.; Mbadiko, C.M.; Gbolo, B.Z.; Lengbiye, E.M.; Kilembe, J.T. Ocimum species as potential bioresources against COVID-19: A review of their Phytochemistry and antiviral activity. Int. J. Pathog. Res. 2020, 5, 42–54. [Google Scholar] [CrossRef]
- Fatiha, E.B.; VM, L.; Hugo, F.; Daniel, C. Reflection on medicinal plants, especially antivirals and how to reconsider ethnobotany as an interesting way for health preservation. Afr. J. Pharm. Pharmacol. 2021, 15, 10–32. [Google Scholar] [CrossRef]
- Abd Rashed, A.; Rathi, D.-N.G. Bioactive components of Salvia and their potential antidiabetic properties: A review. Molecules 2021, 26, 3042. [Google Scholar] [CrossRef] [PubMed]
- Fu, Z.; Wang, H.; Hu, X.; Sun, Z.; Han, C. The pharmacological properties of Salvia essential oils. J. Appl. Pharm. Sci. 2013, 3, 122–127. [Google Scholar]
- Bonesi, M.; Loizzo, M.R.; Acquaviva, R.; Malfa, G.A.; Aiello, F.; Tundis, R. Anti-inflammatory and antioxidant agents from Salvia genus (Lamiaceae): An assessment of the current state of knowledge. Anti-Inflamm. Anti-Allergy Agents Med. Chem. (Former. Curr. Med. Chem.-Anti-Inflamm. Anti-Allergy Agents) 2017, 16, 70–86. [Google Scholar] [CrossRef] [PubMed]
- Vani, S.R.; Cheng, S.; Chuah, C. Comparative study of volatile compounds from genus Ocimum. Am. J. Appl. Sci. 2009, 6, 523–528. [Google Scholar] [CrossRef]
- Zahran, E.M.; Abdelmohsen, U.R.; Khalil, H.E.; Desoukey, S.Y.; Fouad, M.A.; Kamel, M.S. Diversity, phytochemical and medicinal potential of the genus Ocimum L. (Lamiaceae). Phytochem. Rev. 2020, 19, 907–953. [Google Scholar] [CrossRef]
- Pandey, A.K.; Singh, P.; Tripathi, N.N. Chemistry and bioactivities of essential oils of some Ocimum species: An overview. Asian Pac. J. Trop. Biomed. 2014, 4, 682–694. [Google Scholar] [CrossRef]
- Salehi, B.; Mnayer, D.; Özçelik, B.; Altin, G.; Kasapoğlu, K.N.; Daskaya-Dikmen, C.; Sharifi-Rad, M.; Selamoglu, Z.; Acharya, K.; Sen, S. Plants of the genus Lavandula: From farm to pharmacy. Nat. Prod. Commun. 2018, 13, 1934578X1801301037. [Google Scholar] [CrossRef]
- Dobros, N.; Zawada, K.D.; Paradowska, K. Phytochemical Profiling, Antioxidant and Anti-Inflammatory Activity of Plants Belonging to the Lavandula Genus. Molecules 2023, 28, 256. [Google Scholar] [CrossRef]
- Shayista, C.; Zahoor, A.K.; Phalestine, S. Medicinal importance of genus Origanum: A review. J. Pharmacogn. Phytother. 2013, 5, 170–177. [Google Scholar]
- Sharifi-Rad, M.; Berkay Yılmaz, Y.; Antika, G.; Salehi, B.; Tumer, T.B.; Kulandaisamy Venil, C.; Das, G.; Patra, J.K.; Karazhan, N.; Akram, M. Phytochemical constituents, biological activities, and health-promoting effects of the genus Origanum. Phytother. Res. 2021, 35, 95–121. [Google Scholar] [CrossRef]
- García-Beltrán, J.; Esteban, M. Properties and applications of plants of Origanum sp. Genus. SM J. Biol 2016, 2, 1006–1015. [Google Scholar]
- World Intellectual Property Organization. The Patentscope. Available online: https://patentscope.wipo.int (accessed on 29 November 2022).
- United States Patent and Trademark Office. USPTO Database (PatFT-AppFT). Available online: https://uspto.gov/patents/search (accessed on 5 January 2023).
- European Patent Office. Espacenet Patent Search. Available online: https://worldwide.espacenet.com (accessed on 5 January 2023).
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [PubMed]
- Hafiane, F.Z.; Fatimi, A. An emulsion-based formulation for increasing the resistance of plants to salinity stress: US20160302416A1 patent evaluation. Environ. Sci. Proc. 2022, 16, 4. [Google Scholar] [CrossRef]
- Hachimi Alaoui, C.; Fatimi, A. A preparation method of softwood lignin derivatives: US9347177B2 patent evaluation. Environ. Sci. Proc. 2022, 22, 20. [Google Scholar] [CrossRef]
- Fatimi, A. Cellulose-based hydrogels: Patent analysis. J. Res. Updat. Polym. Sci. 2022, 11, 16–24. [Google Scholar] [CrossRef]
- Fatimi, A. A patent data analysis of the innovation trends in biological control agent formulations. Recent Adv. Food Nutr. Agric. 2022, 13, 59–69. [Google Scholar] [CrossRef]
- Fatimi, A. Patentability of biopolymer-based hydrogels. Chem. Proc. 2022, 8, 39. [Google Scholar] [CrossRef]
- Fatimi, A. Hydrogel-based bioinks for three-dimensional bioprinting: Patent analysis. Mater. Proc. 2021, 7, 3. [Google Scholar] [CrossRef]
- Fatimi, A. Chitosan-based hydrogels: Patent analysis. Mater. Proc. 2022, 9, 1. [Google Scholar] [CrossRef]
- Fatimi, A. Trends and recent patents on cellulose-based biosensors. Eng. Proc. 2022, 16, 12. [Google Scholar] [CrossRef]
- Fatimi, A. Seaweed-based biofertilizers: A patent analysis. Recent Pat. Biotechnol. 2022, 16, 144–154. [Google Scholar] [CrossRef] [PubMed]
- Fatimi, A. Sodium tetradecyl sulfate molecule: Patent analysis based on chemical compounds search. Eng. Proc. 2022, 19, 4. [Google Scholar] [CrossRef]
- Fatimi, A. Exploring the patent landscape and innovation of hydrogel-based bioinks used for 3D bioprinting. Recent Adv. Drug Deliv. Formul. 2022, 16, 145–163. [Google Scholar] [CrossRef] [PubMed]
- Hachimi Alaoui, C.; Fatimi, A. A 20-year patent review and innovation trends on hydrogel-based coatings used for medical device biofabrication. J. Biomater. Sci. Polym. Ed. 2023, in press. [CrossRef]
- Reddy, M.S. Selected Multi-Phase Treatment for Coronavirus Respiratory Infections. U.S. Granted Patent US11077052B1, 3 August 2021. [Google Scholar]
- Alkalay, R. Compositions and Methods for Treating and Preventing a Coronavirus Infection. PCT Patent Application WO2021186453A1, 23 September 2021. [Google Scholar]
- Crawford, K. Oral Rinse, Nasal Spray and Methods for Prevention of COVID-19 by Lowering Viral Load of COVID-19. PCT Patent Application WO2022099182A1, 12 May 2022. [Google Scholar]
- Wu, P.; Shi, M. Chinese Herbal Medicine Composition for Inhibiting New Coronal Pneumovirus as well as Application and Preparation Method of Chinese Herbal Medicine Composition. China Patent Application CN114642712A, 21 June 2022. [Google Scholar]
IPC Code | Description |
---|---|
A61P31/14 | Anti-infective agents for the treatment of RNA viruses. |
A61P31/12 | Anti-infective agents have aimed antiviral effects. |
A61k36/53 | Medicinal preparations containing material from Lamiaceae. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
El Boukhari, R.; Fatimi, A. Patent Analysis of Four Lamiaceae-Derived Plants: A Medicinally Active Resource against New Health Challenges. Med. Sci. Forum 2023, 21, 1. https://doi.org/10.3390/ECB2023-14093
El Boukhari R, Fatimi A. Patent Analysis of Four Lamiaceae-Derived Plants: A Medicinally Active Resource against New Health Challenges. Medical Sciences Forum. 2023; 21(1):1. https://doi.org/10.3390/ECB2023-14093
Chicago/Turabian StyleEl Boukhari, Reda, and Ahmed Fatimi. 2023. "Patent Analysis of Four Lamiaceae-Derived Plants: A Medicinally Active Resource against New Health Challenges" Medical Sciences Forum 21, no. 1: 1. https://doi.org/10.3390/ECB2023-14093